
    
      A multi-center, post market, non-randomized trial, designed to obtain safety and efficacy
      data from patients implanted with the size 19mm Model 1000 heart valve. Each enrolled patient
      will be followed until one year post-implantation. Data will be collected both
      retrospectively and prospectively, on patients who were implanted from 1-Jan-2009 to
      31-Dec-2009 with the 19mm Model 1000. The data collected will be pooled with the data
      currently collected, under the U.S. Food and Drug Administration (FDA) IDE Number G01284 for
      submission to the U.S. FDA.
    
  